Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PPAR-G: Pioglitazone for Prevention of Restenosis in Diabetic PCI
NCT00819325Phase 4Completed
- Sponsor
- Queen Elizabeth II Health Sciences Centre
- Start
- Aug 2002
- Primary completion
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pioglitazone in type 2 diabetes mellitus (T2DM), sponsored by Queen Elizabeth II Health Sciences Centre. Started Aug 2002; status: completed.
02
Drugs
pioglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00819325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00819325.